| 19 Nov, 10:19 am | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 11 Nov, 03:08 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange regarding the Earnings call Transcript pertaining to the unaudited financials for the quarter and half year ended September 30, 2025. | nse |
| 11 Nov, 02:53 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 06 Nov, 06:59 pm | — | … | Newspaper Publication w.r.t. Financial Results for the quarter and half year ended September 30, 2025. | nse |
| 06 Nov, 06:27 pm | — | … | Monitoring Agency Report for the quarter ended September 30, 2025 | nse |
| 06 Nov, 06:25 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 06 Nov, 11:09 am | — | … | Solara Active Pharma Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 05 Nov, 06:27 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about audio recording of Q2 FY26 earnings call held on November 05, 2025. | nse |
| 05 Nov, 06:25 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 05 Nov, 03:38 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - General-Updates | bse |
| 05 Nov, 03:37 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange regarding the following items approved at the Board meeting held on November 05, 2025.1. Appointment of Mr. Sarat Kumar, CFO as the Chief Investor Relations Officer2. Change in the remuneration of the Whole Time Director, Mr. Mohan Muthunarayanan3. Change in the remuneration of the eligible Senior Management Personnels.4. Review and confirmation of Risk Management Policy. | nse |
| 05 Nov, 03:16 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended September 30, 2025. | bse |
| 05 Nov, 03:10 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | nse |
| 05 Nov, 03:02 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Intimation Regarding The Grant Of ESOP | bse |
| 05 Nov, 02:51 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange regarding the appointment of Mr. Mohanraj S as Chief Human Resources Officer and designating him as a Senior Management Personnel with immediate effect from November 05, 2025 | nse |
| 05 Nov, 02:44 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Nov, 02:41 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Solara Q2'26 Performance". | nse |
| 05 Nov, 02:35 pm | — | … | Solara Active Pharma Sciences Limited has informed the Exchange regarding Resignation of Mr Kartheek Chintalapati Raju as Non- Executive Director of the company w.e.f. November 05, 2025. | nse |
| 05 Nov, 02:31 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Resignation of Director | bse |
| 05 Nov, 02:17 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025. | bse |
| 05 Nov, 02:16 pm | — | … | Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025 along with the Limited Review Report for the said period. | nse |
| 29 Oct, 04:08 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Quarter And Half Year Ended September 30, 2025. | bse |
| 17 Oct, 11:17 am | — | … | Solara Active Pharma Sciences Limited has informed the exchange about the ESG rating received from Crisil ESG Ratings & Analytics Limited. | nse |
| 14 Oct, 12:06 am | — | … | Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of Shares pursuant to exercise of ESOP Options. | nse |
| 13 Oct, 11:57 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Allotment | bse |
| 26 Sept, 02:00 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Announcement Under Regulation 30 SEBI (LODR) - Clarification | bse |
| 26 Sept, 12:52 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Clarification sought from Solara Active Pharma Sciences Ltd | bse |
| 26 Sept, 10:28 am | — | … | Significant increase in volume has been observed in Solara Active Pharma Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Solara Active Pharma Sciences Limited has submitted their response. | nse |
| 25 Sept, 05:47 pm | — | … | Significant increase in volume has been observed in Solara Active Pharma Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. | nse |
| 04 Sept, 01:04 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 02 Sept, 09:32 pm | — | … | Business Responsibility and Sustainability Report for the Financial year 2024-25 | nse |
| 02 Sept, 09:24 pm | — | … | Solara Active Pharma Sciences Ltd - 541540 - Reg. 34 (1) Annual Report. | bse |